| Daunorubicin investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 93show all (up to 200) |
|---|
| → investigated in trials for | Leukemia 80 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Leukemia | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Myeloid Leukemiahematologic_malignancy 76 trials (31 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Myeloid Leukemia | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Lymphoblastic Leukemia 35 trials (8 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Lymphoblastic Leukemia | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Myelodysplastic Syndromehematologic_malignancy 19 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Myelodysplastic Syndrome | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adult Acute Myeloid Leukemia 16 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Adult Acute Myeloid Leukemia | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lymphoma 12 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Secondary Acute Myeloid Leukemia 11 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Secondary Acute Myeloid Leukemia | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | B Acute Lymphoblastic Leukemia 10 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | B Acute Lymphoblastic Leukemia | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 9 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lymphoblastic Lymphoma 9 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lymphoblastic Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 8 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Childhood Acute Lymphoblastic Leukemia 8 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Childhood Acute Lymphoblastic Leukemia | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | T Acute Lymphoblastic Leukemiahematologic_malignancy 7 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | T Acute Lymphoblastic Leukemia | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acute Myeloid Leukemia Post Cytotoxic Therapy 6 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Acute Myeloid Leukemia Post Cytotoxic Therapy | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adult Acute Monoblastic Leukemia 6 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Adult Acute Monoblastic Leukemia | 6 | Observed | clinicaltrials | graph → |